SkilaMederi Names Ray Joske as Chief Commercial Officer

MORRIS PLAINS, N.J., Jan. 31, 2013 /PRNewswire/ -- Global life sciences strategic advisory and data analytics solutions provider SkilaMederi today announced the appointment of Raymond Joske to its Executive Management Team as Chief Commercial Officer. In this role, Joske will oversee commercial efforts worldwide for SkilaMederi and report directly to CEO Kilian Weiss.

Mr. Joske has more than 28 years of executive experience in the client and support sides of the life sciences industry, including sales, sales management, marketing, new product development, disease management, analytics and market access. At Bristol-Myers Squibb, he held commercial roles in sales management, product marketing and market access. Mr. Joske also served as Senior Vice President of Marketing, Business Development and International Sales and Marketing for a Merck KGaA affiliate, and Senior Vice President of the Healthcare Analytics Group, a division of Gallagher Benefit Services. Before joining SkilaMederi, Mr. Joske oversaw new product development and marketing for MediMedia^® Health, a provider of multichannel promotional health care-related campaigns.

"Ray offers the breadth of business development and marketing experience that will advance SkilaMederi's position as a unique life sciences advisory firm that harnesses expert counsel, big data analytics and other knowledge tools to deliver the predictive insight our clients need to achieve a competitive advantage," said SkilaMederi CEO Kilian Weiss. "We look forward to his contribution as SkilaMederi embarks on this next stage of growth."

For more information on SkilaMederi, please visit www.skilamederi.com.

About SkilaMederi
SkilaMederi is a specialized life sciences advisory firm that leverages big data and social network analytics to produce the predictive insight pharmaceutical and bioscience clients need to successfully position, launch and market new products. With deep life sciences industry expertise anchoring comprehensive service offerings, SkilaMederi provides strategic insight, social network analytics and knowledge-based tools distinct from conventional consultancies that offer only a few localized specialists or off-the-shelf software. SkilaMederi's tailored portfolio of strategic and analytics services draws upon its globally-networked subject matter experts and incisive "human crowd-sourced intelligence" data-gathering methods. The strength of those combined assets explains why the world's leading life science organizations turn to SkilaMederi to develop the most productive solutions for the most difficult challenges.

SkilaMederi has offices in the United States, Germany, the United Kingdom, France, and Ukraine.

SOURCE SkilaMederi